NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer

被引：0
|
作者：
Meng Ren
Hongyu Zhao
Yan Gao
Qi Chen
Xiaoting Zhao
Wentao Yue
机构：
[1] Capital Medical University,Central Laboratory, Beijing Obstetrics and Gynecology Hospital
[2] Beijing Maternal and Child Health Care Hospital,undefined
[3] Center for Discovery and Innovation,undefined
[4] Hackensack Meridian Health,undefined
来源：
Journal of Ovarian Research | / 16卷
关键词：
NUF2; Ovarian cancer; HNRNPA2B1; PI3K/AKT/mTOR signaling pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] AMPH1 functions as a tumour suppressor in ovarian cancer via the inactivation of PI3K/AKT pathway
    Chen, Yajun
    Cao, Wenjiao
    Wang, Lihua
    Zhong, Tianying
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (13) : 7652 - 7659
  • [32] Tumour-derived exosomal miR-205 promotes ovarian cancer cell progression through M2 macrophage polarization via the PI3K/Akt/mTOR pathway
    He, Liuqing
    Chen, Quan
    Wu, Xiaoying
    JOURNAL OF OVARIAN RESEARCH, 2025, 18 (01)
  • [33] MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance
    Gasparri, Maria Luisa
    Besharat, Zein Mersini
    Farooqi, Ammad Ahmad
    Khalid, Sumbul
    Taghavi, Katayoun
    Besharat, Raad Aris
    Sabato, Claudia
    Papadia, Andrea
    Panici, Pierluigi Benedetti
    Mueller, Michael David
    Ferretti, Elisabetta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (12) : 2313 - 2318
  • [34] MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance
    Maria Luisa Gasparri
    Zein Mersini Besharat
    Ammad Ahmad Farooqi
    Sumbul Khalid
    Katayoun Taghavi
    Raad Aris Besharat
    Claudia Sabato
    Andrea Papadia
    Pierluigi Benedetti Panici
    Michael David Mueller
    Elisabetta Ferretti
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2313 - 2318
  • [35] CADM1 inhibits ovarian cancer cell proliferation and migration by potentially regulating the PI3K/Akt/mTOR pathway
    Si, Xiaoqiang
    Xu, Feixue
    Xu, Feihua
    Wei, Min
    Ge, Yan
    Chenge, Shuyi
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 123
  • [36] Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer
    Rinne, Natasha
    Christie, Elizabeth L.
    Ardasheva, Anastasia
    Kwok, Chun Hei
    Demchenko, Nikita
    Low, Caroline
    Tralau-Stewart, Catherine
    Fotopoulou, Christina
    Cunnea, Paula
    CANCER DRUG RESISTANCE, 2021, 4 (03) : 573 - 595
  • [37] Aclidinium inhibits proliferation and metastasis of ovarian cancer SKOV3 cells via downregulating PI3K/AKT/mTOR signaling pathway
    Qiao, Juan
    Wang, Wei-Jing
    Zhang, Yuan
    ONCOLOGY LETTERS, 2018, 16 (05) : 6417 - 6422
  • [38] Hypoxia-induced miR-9 expression promotes ovarian cancer progression via activating PI3K/AKT/mTOR/GSK3β signaling pathway
    Zhu, Wen-Jing
    Huang, Huan-Huan
    Feng, Yi-Fan
    Zhan, Lei
    Yang, Jian
    Zhu, Lin
    Wang, Qing-Yuan
    Wei, Bing
    Wang, Wen-Yan
    NEOPLASMA, 2023, 70 (02) : 216 - 228
  • [39] CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
    Zi, Dan
    Li, Qing
    Xu, Cheng-xiong
    Zhou, Zhi-Wei
    Song, Guan-Bin
    Hu, Cheng-Bin
    Wen, Fang
    Yang, Han-Lin
    Nie, Lei
    Zhao, Xing
    Tan, Jun
    Zhou, Shu-Feng
    He, Zhi-Xu
    AGING-US, 2022, 14 (11): : 4673 - 4698
  • [40] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhang, Zhenyu
    Zhu, Jinfeng
    Huang, Yansong
    Li, Weibing
    Cheng, Hongqiu
    DIAGNOSTIC PATHOLOGY, 2018, 13
12345